Microbiome Forum Lectures

Jan Suchodolski, MedVet, DrVetMed, PhD, AGAF, DACVM Melanie Werner, Dr med vet, DECVIM-CA Katie Tolbert, DVM, PhD, DACVIM (SAIM) Jessica Quimby, DVM, DACVIM (SAIM), PhD Julie Spears, PhD Holger Volk, DVM, DECVN, PhD, PGCAP, FHEA, MRCVS Natalia

The speakers appearing during Day 2 of the Purina Institute Microbiome Forum 2023 join Dr. Jan Suchodolski to answer questions submitted by audience members. Dr. Natalia Wagemans delivers closing remarks.

Jessica Quimby, DVM, DACVIM (SAIM), PhD

Get new insights into how the gut microbiome, uremic toxins, hydration, and diet interact to influence the health of cats with chronic kidney disease.

Learn from globally renowned experts about evidence-based, clinically relevant microbiome science for practicing veterinarians.

Jan Suchodolski, MedVet, DrVetMed, PhD, AGAF, DACVM

Learn how dysbiosis is defined, how to evaluate intestinal dysbiosis using the dysbiosis index, and how to interpret the results obtained during acute and chronic conditions.

Linda Toresson, DVM, PhD

How to interpret microbiome testing results in dogs with chronic enteropathies, when to suspect bile acid diarrhea, and how dysbiosis index results can be used to guide chronic enteropathy management.

Jan Suchodolski, MedVet, DrVetMed, PhD, AGAF, DACVM

Julia Fritz, DECVCN, FTÄ Tierernährung und Diätetik

Fabio Procoli, DMV, MVetMed, DACVIM, DECVIM-CA (Internal Medicine), MRCVS

Linda Toresson, DVM, PhD

Jenessa Winston, DVM, PhD, DACV

Leading experts discuss management of difficult canine and feline chronic enteropathy cases with an emphasis on practical, evidence-based advice for veterinarians.

Jörg M. Steiner, Med Vet, Dr Med Vet, PhD, DACVIM-SAIM, DECVIM-CA, AGAF

Hear a brief overview of intestinal microbiota composition and importance, followed by an in-depth review of different methods for evaluating the gut microbiota with a focus on assay practicality and feasibility.

Jan Suchodolski, MedVet, DrVetMed, PhD, AGAF, DACVM

Discover how no single test allows proper assessment of the gut microbiota and its function and why a combination of molecular tools, with an emphasis on the gut dysbiosis index, is needed for case management.